From Bio Co

From Bio Co Debt/EBITDA

The Total Debt to EBITDA Ratio of From Bio Co (377220.KQ) as of Oct 28, 2026 is -0.08. In the previous year, Total Debt to EBITDA Ratio was -0.20 — a change of -60.99% (higher).

Debt/EBITDA

-0.08

YoY

-60.99%

Last updated:

Total Debt to EBITDA Ratio of From Bio Co is 2025 -0.08 . Total Debt to EBITDA Ratio of From Bio Co was 2024 -0.20 . It decreases by -60.99% higher compared to the previous year.

The From Bio Co Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2019
1.16 KRW
Jan 1, 2020
0.18 KRW
Jan 1, 2021
0.02 KRW
Jan 1, 2022
0.16 KRW
Jan 1, 2024
-0.20 KRW
Jan 1, 2025
-0.08 KRW
The From Bio Co Debt/EBITDA history
YEARDebt/EBITDAYoY
-0.08-60.99%
-0.20-222.90%
0.16+895.02%
0.02-91.12%
0.18-84.33%
1.16—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

From Bio Co Stock analysis

What does From Bio Co do? From Bio Co., Ltd. generates revenue through the production and sale of health functional foods, including products targeting joint health, stomach health, eye health, and sleep health. The company also sells wild mango and other diet foods, alongside skincare items such as creams, shampoos, and soaps. Its primary customers are consumers seeking wellness solutions across multiple health categories, with a focus on natural and functional dietary supplements. The firm's product portfolio includes functional foods under specific health categories, with no additional brands or segments mentioned in the description. Revenue streams are derived directly from the sale of these products to end consumers, with no reference to third-party partnerships or distribution channels. The company's offerings are designed to address common health concerns through dietary and skincare solutions. From Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about From Bio Co stock

Total Debt to EBITDA Ratio of From Bio Co is -0.08 in 2025.

Total Debt to EBITDA Ratio of From Bio Co changed from -0.20 to -0.08, representing a -60.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio From Bio Co since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's From Bio Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — From Bio Co

All Key Metrics — From Bio Co